Suchergebnisse - "Carlos K. H. Wong"

PubPharm (19)

1

Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort

in: Frontiers in Endocrinology | 2022

von Carlos K. H. Wong | Carlos K. H. Wong | Carlos K. H. Wong | +12

2

Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

in: Journal of Hematology & Oncology | 2022

von Wei Kang | Jessica J. P. Shami | Vincent K. C. Yan | +10

3

Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2022

von Kristy T. K. Lau | Carlos K. H. Wong | Ivan C. H. Au | +4

4

Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone

in: Frontiers in Pharmacology | 2022

von Carlos K. H. Wong | Carlos K. H. Wong | Carlos K. H. Wong | +9

5

Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia

in: JTO Clinical and Research Reports | 2022

von Herbert H. Loong, M. | Carlos K.H. Wong, P. | Catherine P.K. Chan, P. | +4

6

Associations of Family Meals with Adolescent Perception of Family Relationship and Compliance with Parental Guidance in Hong Kong: Results of a Representative Cross-Sectional Survey

in: International Journal of Environmental Research and Public Health | 2021

von Rosa S. Wong | Keith T. S. Tung | Wilfred H. S. Wong | +6

7

Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment.

in: PLoS Medicine | 2021

von Jiaxi Zhao | Hao Wang | Xue Li | +9

8

Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis

in: EClinicalMedicine | 2021

von Carlos K.H. Wong | Eric Y.F. Wan | Sihui Luo | +10

9

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

in: Cost Effectiveness and Resource Allocation | 2020

von Herbert H. Loong | Carlos K. H. Wong | Linda K. S. Leung | +5

10

Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy

in: BMC Nephrology | 2020

von Carlos K. H. Wong | Julie Chen | Samuel K. S. Fung | +7